Print

HVTN 052

A Phase IB Clinical Trial to Evaluate the Safety and Immunogenicity of a Multiclade HIV-1 DNA Plasmid Vaccine, VRC-HIVDNA009-00-VP, Administered at 2 Different Dosing Schedules, in HIV-1-Uninfected Adult Participants

Trial Details:

Ib Completed
HIV Vaccine Trials Network (HVTN) December 01, 2003
VRC-HIVDNA009-00-VP gag B, gol B, nef B, env A, env B, env C
VRC-HIVDNA009-00-VP DNA
USA 180
NCT00071851
http://clinicaltrials.gov/show/NCT00071851